This memorandum documents what public evidence exists about DealShare's corporate structure, funding history, business claims, and current operating status, and keeps that evidence apart from interpretation of it. The scope is limited to information available through public web sources as of the reference date.
dealshare.in · Data reference date: 20 September 2026
DealShare (Merabo Labs Private Limited, CIN U74999RJ2018PTC062179) reached a $1.7B valuation in 2022, and FY25 revenue is reported at INR 432 Cr (down 13.4%) with a net loss of INR 87.65 Cr; press reports in August and September 2026 describe the online business as largely shut and a low-priced sale under discussion, based on unnamed sources and not confirmed by the company.
Reproduced from the review's own summary table: what evidence exists for each category, whether it can be independently verified, and its resulting status.
A dated company statement on current operating status, including whether online ordering is active and how open orders and balances are handled.
Read the full structural evidence review.